Myriad Genetics MYGN Earnings Call Transcripts

NASDAQ MYGN
$5.70 -0.21 (-3.55%)
At close: Nov 9, 2026 · 4:00 PM EST
9 earnings calls on file for Myriad Genetics, from Q2 2020 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Myriad Genetics Q3 2026 Earnings Call

Nov 4, 2026 4,533 words · 20 min read
  • Matthew ScaloSenior Vice President of Investor Relations
  • Sam RahaPresident and Chief Executive Officer
  • Ben WheelerChief Financial Officer
  • Vishal SikriExecutive Vice President of Commercial
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Myriad Genetics Earnings Call Transcripts

Calls9
LatestNov 4, 2026
SinceQ2 2020

Fiscal 2026

Fiscal 2025

Fiscal 2021

Fiscal 2020

All 9 Myriad Genetics transcripts Register to get access to Myriad Genetics’s earnings call transcripts.